Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of HLX01 vs Rituximab in CD20+ B-cell Lymphoma
NCT02584920Phase 2Completed
- Sponsor
- Henlius
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in B-cell non-Hodgkin lymphoma, sponsored by Henlius. Started Oct 2014; status: completed.
02
Drugs
rituximab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02584920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584920.